The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren’s syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren’s syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial

Published:2018-10-02 Issue:3 Volume:38 Page:657-664
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Liu Xia,Li Xiaomei,Li Xiangpei,Li Zhijun,Zhao Dongbao,Liu Shengyun,Zhang Miaojia,Zhang Fengxiao,Zhu Ping,Chen Jinwei,Wei Wei,Lin Bing,Zhou Yingbo,Chen Jing,Pang Yafei,Zhang Lei,Sun Xiaoxuan,Yu Zhibo,Jia Yun,Wang Jia,Sun Wenwen,Chiu Frank,Pang Liping,Wang Guochun

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/article/10.1007/s10067-018-4315-8/fulltext.html

Reference28 articles.

1. Youinou P, Pers JO (2015) Primary Sjogren's syndrome at a glance today. Joint Bone Spine 82(2):75–76. https://doi.org/10.1016/j.jbspin.2014.10.018

2. Ramos-Casals M, Tzioufas AG, Stone JH, Siso A, Bosch X (2010) Treatment of primary Sjogren syndrome: a systematic review. JAMA 304(4):452–460. https://doi.org/10.1001/jama.2010.1014

3. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558

4. Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol 175(3):1167–1177. https://doi.org/10.2353/ajpath.2009.090319

5. De Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher JD, 3rd, Fang B, Zheng X, Ma P, Farley WJ, Siemasko KF, Niederkorn JY, Stern ME, Li DQ, Pflugfelder SC (2009) IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2 (3):243–253. doi: https://doi.org/10.1038/mi.2009.5

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunoregulatory effects of total glucosides of peony in autoimmune diseases;Journal of Leukocyte Biology;2024-04-16

2. Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group;Seminars in Arthritis and Rheumatism;2024-04

3. Use of Complementary and Alternative Medicine by Patients Treated for Systemic Lupus Erythematosus, Primary Sjögren’s Syndrome, or Systemic Sclerosis in a French Rural Region;Complementary Medicine Research;2024

4. Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases;RMD Open;2023-12

5. Combined use of total glucosides of paeony and hydroxychloroquine in primary Sjögren's syndrome: A systematic review;Immunity, Inflammation and Disease;2023-10